CardiAQ Valve Technologies
United States
acquired
acquired
Stage
About
Developed transcatheter mitral valve replacement (TMVR) devices for treating mitral valve disease such as mitral regurgitation, enabling minimally invasive, catheter-based valve implantation. The company focused on structural heart medical devices for cardiology interventions.
Explore CardiAQ Valve Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.